missing translation for 'onlineSavingsMsg'
Learn More

SB-222200, MedChemExpress

Product Code. 16462847
Encompass_Preferred
Click to view available options
Quantity:
10 mg
50 mg
Unit Size:
10mg
50mg
This item is not returnable. View return policy

Product Code. 16462847

Brand: Medchem Express HY15722

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress SB-222200 is a potent, selective, orally active and blood-brain barrier (BBB) penetrant NK-3 receptor antagonist. SB-222200 is developed for central nervous system (CNS) disorders.

SB-222200 is a potent, selective, orally active and blood-brain barrier (BBB) penetrant NK-3 receptor antagonist. SB-222200 is developed for central nervous system (CNS) disorders.

Specifications

Chemical Name or Material SB-222200
CAS 174635-69-9
Color Off-White
Purity Grade Notes Research
Molecular Formula C26H24N2O
Quantity 50 mg
Solubility Information DMSO : ≥ 100 mg/mL (262.83 mM)
SMILES O=C(C1=C(C)C(C2=CC=CC=C2)=NC3=CC=CC=C13)N[C@H](C4=CC=CC=C4)CC
Molecular Weight (g/mol) 380.48
Formula Weight 380.48
Percent Purity 98.57%
Grade Research
Physical Form Solid
For Use With (Application) Neuroscience-Neuromodulation
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.

Gracias por ayudarnos a mejorar nuestra web. Su comentario ha sido enviado